Edition:
United States

Dr. Lal PathLabs Ltd (DLPA.NS)

DLPA.NS on National Stock Exchange of India

962.45INR
14 Dec 2018
Change (% chg)

Rs-4.45 (-0.46%)
Prev Close
Rs966.90
Open
Rs964.90
Day's High
Rs981.00
Day's Low
Rs951.35
Volume
44,187
Avg. Vol
86,408
52-wk High
Rs1,122.00
52-wk Low
Rs798.40

Latest Key Developments (Source: Significant Developments)

Dr. Lal Pathlabs Says NCLT Sanctioned Scheme Of Amalgamation With Delta Ria And Pathology
Friday, 14 Dec 2018 02:29am EST 

Dec 14 (Reuters) - Dr. Lal PathLabs Ltd ::NCLT SANCTIONED SCHEME OF AMALGAMATION BETWEEN CO AND DELTA RIA AND PATHOLOGY PVT LTD.  Full Article

Dr. Lal Pathlabs March-qtr Consol Profit Rises
Monday, 14 May 2018 07:32am EDT 

May 14 (Reuters) - Dr. Lal PathLabs Ltd ::RECOMMENDED DIVIDEND OF 3 RUPEES PER SHARE.MARCH QUARTER CONSOL PROFIT 401 MILLION RUPEES VERSUS PROFIT 314 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.67 BILLION RUPEES VERSUS 2.20 BILLION RUPEES YEAR AGO.  Full Article

Dr.Lal Pathlabs Says NCLT Ordered Meetings of Shareholder, Unsecured Creditors For Amalgamation Scheme With Delta Ria And Pathology​​
Friday, 29 Dec 2017 01:50am EST 

Dec 29 (Reuters) - Dr. Lal Pathlabs Ltd ::NCLT ORDERED MEETINGS OF SHAREHOLDERS, UNSECURED CREDITORS TO APPROVE SCHEME OF AMALGAMATION BETWEEN CO & DELTA RIA AND PATHOLOGY​.  Full Article

Dr. Lal Pathlabs Says Unit Approves Acquisition Of Satya Pathology And Diagnostic Centre
Tuesday, 12 Dec 2017 06:49am EST 

Dec 12 (Reuters) - Dr. Lal Pathlabs Ltd ::SAYS UNIT APPROVES ACQUISITION OF SATYA PATHOLOGY AND DIAGNOSTIC CENTRE.SAYS COST OF ACQUISITION NOT EXCEEDING 20 MILLION RUPEES.  Full Article

India's Dr. Lal Pathlabs Sept-qtr profit falls
Thursday, 9 Nov 2017 03:55am EST 

Nov 9 (Reuters) - Dr. Lal Pathlabs Ltd ::Sept quarter profit 502 million rupees versus 528 million rupees year ago.Sept quarter revenue from operations 2.69 billion rupees versus 2.53 billion rupees year ago.Declared interim dividend of 1.50 rupees per share.  Full Article